{
  "_originalData": {
    "identity": {
      "bacteriumName": "Aeromonas sp.",
      "aliases": [
        "Aeromonas hydrophila",
        "Aeromonas veronii",
        "Aeromonas shubertii"
      ],
      "lastUpdated": "2024-03-26",
      "clsiCategory": "Other Non-Enterobacterales",
      "classification": {
        "gramStain": "Gram-negative",
        "morphology": "Bacilli",
        "respiration": "Aerobic",
        "notes": []
      },
      "strainDetails": [
        {
          "type": "Species",
          "value": "Aeromonas hydrophila",
          "notes": "Most common species"
        },
        {
          "type": "Species",
          "value": "Aeromonas veronii",
          "notes": ""
        },
        {
          "type": "Species",
          "value": "Aeromonas shubertii",
          "notes": ""
        }
      ],
      "biochemicalTests": "Gram-negative rod, oxidase +, motile (single polar flagellum), ferments glucose, indole +, resistant to vibriostatic agent O/129."
    },
    "clinicalProfile": {
      "summary": "Aeromonas species are gram-negative bacilli found in aquatic environments that can cause gastroenteritis, wound infections, and bacteremia, particularly after exposure to contaminated water or medicinal leeches.",
      "pathophysiologyPearls": [
        "Infections are often linked to exposure to fresh, brackish, or marine water.",
        "Can be part of the oral flora of leeches, leading to infections after their use.",
        "Several species exist with variable antimicrobial susceptibility, necessitating culture and susceptibility testing."
      ],
      "keySignsAndSymptoms": [
        "Diarrhea (can be watery or bloody)",
        "Wound inflammation, pain, and purulent discharge",
        "Fever and signs of sepsis in bacteremic cases"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Gastroenteritis",
          "description": "The most common clinical presentation. It is a recognized cause of Traveler's diarrhea."
        },
        {
          "syndromeName": "Wound Infections",
          "description": "Occur post-trauma or after exposure to contaminated water or leeches."
        },
        {
          "syndromeName": "Bacteremia",
          "description": "Can occur, often secondary to wound infections or gastroenteritis."
        }
      ],
      "stagesOfIllness": [],
      "highRiskPopulations": [
        "Travelers",
        "Individuals with traumatic water-exposure injuries",
        "Patients undergoing leech therapy"
      ],
      "transmissionVectors": [
        "Contaminated water (fresh, brackish, marine)",
        "Leeches"
      ],
      "prognosisNotes": []
    },
    "resistanceProfile": {
      "groupIntrinsicResistance": [
        {
          "drugOrClass": "Ampicillin",
          "notes": "Uniformly resistant."
        },
        {
          "drugOrClass": "Penicillin",
          "notes": "Uniformly resistant."
        },
        {
          "drugOrClass": "Cefazolin",
          "notes": "Uniformly resistant."
        }
      ],
      "intrinsicResistance": [],
      "majorMechanisms": [
        {
          "mechanismName": "Beta-lactamase Production",
          "mechanismType": "Enzymatic Inactivation",
          "description": "Aeromonas species can produce a variety of beta-lactamases, including ESBLs, AmpC cephalosporinases, and carbapenemases (including metallo-carbapenemases), conferring resistance to a broad range of beta-lactam antibiotics."
        }
      ],
      "clinicalAlerts": [
        {
          "alertTitle": "Geographic Resistance Variation",
          "details": "Resistance to beta-lactams and fluoroquinolones has been recognized in selected areas of the world."
        },
        {
          "alertTitle": "Ciprofloxacin Resistance Post-Leech Therapy",
          "details": "Ciprofloxacin-resistant Aeromonas has been reported following leech therapy."
        }
      ]
    },
    "treatment": {
      "generalNotes": [
        "Empiric therapy should be guided by the severity of infection and local resistance patterns, pending culture and susceptibility results.",
        "Most strains are susceptible to antipseudomonal aminoglycosides, carbapenems, and tetracyclines."
      ],
      "drugsToAvoid": [],
      "adjunctiveTherapies": [],
      "regimens": [
        {
          "context": {
            "type": "Empiric",
            "condition": "Severe Wound Infection",
            "patientPopulation": [
              "Adults"
            ],
            "isolateSource": "Wound"
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "Varies with wound severity and clinical response",
                  "drugs": [
                    {
                      "drugName": "Ciprofloxacin",
                      "dose": "400mg IV or 750mg PO",
                      "route": "IV/PO",
                      "frequency": "BID",
                      "comments": ""
                    },
                    {
                      "drugName": "Levofloxacin",
                      "dose": "750",
                      "route": "IV",
                      "frequency": "daily",
                      "comments": "Differences in susceptibility by species and by geography."
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "Varies with wound severity and clinical response",
                  "drugs": [
                    {
                      "drugName": "TMP-SMX",
                      "dose": "8-10 mg/kg/day",
                      "route": "IV",
                      "frequency": "divided q6h or q8h",
                      "comments": "Based on trimethoprim component."
                    },
                    {
                      "drugName": "Ceftriaxone",
                      "dose": "2",
                      "route": "IV",
                      "frequency": "daily",
                      "comments": ""
                    },
                    {
                      "drugName": "Cefepime",
                      "dose": "2",
                      "route": "IV",
                      "frequency": "q8h",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Empiric",
            "condition": "Gastroenteritis (Traveler's Diarrhea)",
            "patientPopulation": [
              "Adults"
            ],
            "isolateSource": "Stool"
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "3 days",
                  "drugs": [
                    {
                      "drugName": "Ciprofloxacin",
                      "dose": "500",
                      "route": "PO",
                      "frequency": "BID",
                      "comments": ""
                    },
                    {
                      "drugName": "Levofloxacin",
                      "dose": "500",
                      "route": "PO",
                      "frequency": "daily",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": [
                "Oral fluoroquinolones are chelated by multi-valent cations: avoid concomitant oral calcium (dairy products), iron, magnesium or other multivalent cations an hour before or for one hour after dosing."
              ]
            },
            {
              "preference": "Alternative",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "3 days",
                  "drugs": [
                    {
                      "drugName": "TMP-SMX DS",
                      "dose": "1 tab",
                      "route": "PO",
                      "frequency": "BID",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        }
      ]
    },
    "laboratoryProfile": {
      "testingIndications": [
        "Culture and susceptibility testing of infected wound, stool, and blood is necessary due to variable antimicrobial susceptibility among species."
      ],
      "methodologyNotes": [],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    },
    "additionalInformation": {
      "diagnosticNotes": {
        "summary": "",
        "biosafetyWarning": "",
        "methods": []
      },
      "preventionAndScreening": [],
      "treatmentLifecycle": [],
      "antimicrobialStewardship": [
        "If in vitro resistance to one or more of the above regimens is found, another alternative is combining doxycycline with either a fluoroquinolone or an extended-spectrum cephalosporin."
      ],
      "drugSpecificPearls": [],
      "guidelineReferences": [
        {
          "source": "The Lancet",
          "citation": "Lancet 381:1686, 2013",
          "summaryOrNote": "Article on leech-associated infections."
        },
        {
          "source": "Journal of Clinical Microbiology",
          "citation": "J Clin Micro 51:1324, 2013",
          "summaryOrNote": "Report on ciprofloxacin-resistant Aeromonas following leech therapy."
        },
        {
          "source": "Antimicrobial Agents and Chemotherapy",
          "citation": "Antimicrob Agents Chemother 56:1110, 2012",
          "summaryOrNote": "Information on susceptibility to aminoglycosides, carbapenems, and tetracyclines."
        },
        {
          "source": "Clinics in Laboratory Medicine",
          "citation": "Clinics in Lab Med 35:313, 2015",
          "summaryOrNote": "Information on beta-lactamase production in Aeromonas species."
        }
      ]
    }
  },
  "_metadata": {
    "originalKeys": [
      "identity",
      "clinicalProfile",
      "resistanceProfile",
      "treatment",
      "laboratoryProfile",
      "additionalInformation"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.322Z",
    "sourceFormat": "modern"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "identity.bacteriumName"
      ],
      "value": "Aeromonas sp."
    },
    "aliases": {
      "sources": [
        "identity.aliases"
      ],
      "value": [
        "Aeromonas hydrophila",
        "Aeromonas veronii",
        "Aeromonas shubertii"
      ]
    },
    "lastUpdated": {
      "sources": [
        "identity.lastUpdated"
      ],
      "value": "2024-03-26"
    },
    "classification": {
      "sources": [
        "identity.classification"
      ],
      "value": {
        "gramStain": "Gram-negative",
        "morphology": "Bacilli",
        "respiration": "Aerobic",
        "notes": []
      }
    }
  },
  "clinicalInformation": {
    "sources": [
      "clinicalProfile"
    ],
    "value": {
      "summary": "Aeromonas species are gram-negative bacilli found in aquatic environments that can cause gastroenteritis, wound infections, and bacteremia, particularly after exposure to contaminated water or medicinal leeches.",
      "pathophysiologyPearls": [
        "Infections are often linked to exposure to fresh, brackish, or marine water.",
        "Can be part of the oral flora of leeches, leading to infections after their use.",
        "Several species exist with variable antimicrobial susceptibility, necessitating culture and susceptibility testing."
      ],
      "keySignsAndSymptoms": [
        "Diarrhea (can be watery or bloody)",
        "Wound inflammation, pain, and purulent discharge",
        "Fever and signs of sepsis in bacteremic cases"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Gastroenteritis",
          "description": "The most common clinical presentation. It is a recognized cause of Traveler's diarrhea."
        },
        {
          "syndromeName": "Wound Infections",
          "description": "Occur post-trauma or after exposure to contaminated water or leeches."
        },
        {
          "syndromeName": "Bacteremia",
          "description": "Can occur, often secondary to wound infections or gastroenteritis."
        }
      ],
      "stagesOfIllness": [],
      "highRiskPopulations": [
        "Travelers",
        "Individuals with traumatic water-exposure injuries",
        "Patients undergoing leech therapy"
      ],
      "transmissionVectors": [
        "Contaminated water (fresh, brackish, marine)",
        "Leeches"
      ],
      "prognosisNotes": []
    }
  },
  "resistanceInformation": {
    "sources": [
      "resistanceProfile"
    ],
    "value": {
      "groupIntrinsicResistance": [
        {
          "drugOrClass": "Ampicillin",
          "notes": "Uniformly resistant."
        },
        {
          "drugOrClass": "Penicillin",
          "notes": "Uniformly resistant."
        },
        {
          "drugOrClass": "Cefazolin",
          "notes": "Uniformly resistant."
        }
      ],
      "intrinsicResistance": [],
      "majorMechanisms": [
        {
          "mechanismName": "Beta-lactamase Production",
          "mechanismType": "Enzymatic Inactivation",
          "description": "Aeromonas species can produce a variety of beta-lactamases, including ESBLs, AmpC cephalosporinases, and carbapenemases (including metallo-carbapenemases), conferring resistance to a broad range of beta-lactam antibiotics."
        }
      ],
      "clinicalAlerts": [
        {
          "alertTitle": "Geographic Resistance Variation",
          "details": "Resistance to beta-lactams and fluoroquinolones has been recognized in selected areas of the world."
        },
        {
          "alertTitle": "Ciprofloxacin Resistance Post-Leech Therapy",
          "details": "Ciprofloxacin-resistant Aeromonas has been reported following leech therapy."
        }
      ]
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "modern"
      },
      "standardizedRegimens": [
        {
          "regimenId": "modern-0-0-0",
          "extractedFrom": "treatment.regimens[0].recommendations[0].steps[0]",
          "context": {
            "type": "empiric",
            "condition": "Severe Wound Infection",
            "severity": "severe",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": "Wound"
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Ciprofloxacin",
              "dose": "400mg IV or 750mg PO",
              "route": "IV/PO",
              "frequency": "BID",
              "duration": "Varies with wound severity and clinical response",
              "comments": "",
              "originalText": "Ciprofloxacin 400mg IV or 750mg PO IV/PO BID"
            },
            {
              "drugName": "Levofloxacin",
              "dose": "750",
              "route": "IV",
              "frequency": "daily",
              "duration": "Varies with wound severity and clinical response",
              "comments": "Differences in susceptibility by species and by geography.",
              "originalText": "Levofloxacin 750 IV daily"
            }
          ]
        },
        {
          "regimenId": "modern-0-1-0",
          "extractedFrom": "treatment.regimens[0].recommendations[1].steps[0]",
          "context": {
            "type": "empiric",
            "condition": "Severe Wound Infection",
            "severity": "severe",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": "Wound"
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "TMP-SMX",
              "dose": "8-10 mg/kg/day",
              "route": "IV",
              "frequency": "divided q6h or q8h",
              "duration": "Varies with wound severity and clinical response",
              "comments": "Based on trimethoprim component.",
              "originalText": "TMP-SMX 8-10 mg/kg/day IV divided q6h or q8h"
            },
            {
              "drugName": "Ceftriaxone",
              "dose": "2",
              "route": "IV",
              "frequency": "daily",
              "duration": "Varies with wound severity and clinical response",
              "comments": "",
              "originalText": "Ceftriaxone 2 IV daily"
            },
            {
              "drugName": "Cefepime",
              "dose": "2",
              "route": "IV",
              "frequency": "q8h",
              "duration": "Varies with wound severity and clinical response",
              "comments": "",
              "originalText": "Cefepime 2 IV q8h"
            }
          ]
        },
        {
          "regimenId": "modern-1-0-0",
          "extractedFrom": "treatment.regimens[1].recommendations[0].steps[0]",
          "context": {
            "type": "empiric",
            "condition": "Gastroenteritis (Traveler's Diarrhea)",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": "Stool"
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Ciprofloxacin",
              "dose": "500",
              "route": "PO",
              "frequency": "BID",
              "duration": "3 days",
              "comments": "",
              "originalText": "Ciprofloxacin 500 PO BID"
            },
            {
              "drugName": "Levofloxacin",
              "dose": "500",
              "route": "PO",
              "frequency": "daily",
              "duration": "3 days",
              "comments": "",
              "originalText": "Levofloxacin 500 PO daily"
            }
          ]
        },
        {
          "regimenId": "modern-1-1-0",
          "extractedFrom": "treatment.regimens[1].recommendations[1].steps[0]",
          "context": {
            "type": "empiric",
            "condition": "Gastroenteritis (Traveler's Diarrhea)",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": "Stool"
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "TMP-SMX DS",
              "dose": "1 tab",
              "route": "PO",
              "frequency": "BID",
              "duration": "3 days",
              "comments": "",
              "originalText": "TMP-SMX DS 1 tab PO BID"
            }
          ]
        }
      ]
    }
  },
  "laboratoryData": {
    "sources": [
      "laboratoryProfile"
    ],
    "value": {
      "testingIndications": [
        "Culture and susceptibility testing of infected wound, stool, and blood is necessary due to variable antimicrobial susceptibility among species."
      ],
      "methodologyNotes": [],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object"
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {}
  }
}